Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia. - Suppr | 超能文献

Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.

作者信息

Champlin R, Giralt S, Przepiorka D, Ho W, Lee K, Gajewski J, Nimer S, Andersson B, Wallerstein R, Ippolito C

机构信息

MD Anderson Cancer Center, Houston, Texas.

出版信息

Prog Clin Biol Res. 1992;377:385-94; discussion 395-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.

Prog Clin Biol Res. 1992;377:385-94; discussion 395-8.

2

Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.

Transplant Proc. 1991 Feb;23(1 Pt 2):1695-6.

3

Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.在首次慢性期的慢性髓性白血病患者中，去除CD4的移植物中低剂量供体CD8 +细胞可预防异基因骨髓移植排斥反应和严重的移植物抗宿主病。

Bone Marrow Transplant. 1997 Dec;20(11):945-52. doi: 10.1038/sj.bmt.1701008.

4

Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.

Prog Clin Biol Res. 1992;377:405-10.

5

Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.移植物抗白血病效应和移植物抗宿主病中的同种特异性CD8 + Tc1和Tc2细胞群

J Immunol. 1996 Dec 1;157(11):4811-21.

6

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.来自基因分型 HLA 不相同的相关供体的 CD6+ T 细胞耗竭的异基因骨髓移植。

Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.

7

Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation.

Prog Clin Biol Res. 1994;389:523-32.

8

Italian survey on allogeneic BMT for chronic myeloid leukaemia.意大利关于慢性粒细胞白血病异基因骨髓移植的调查。

Bone Marrow Transplant. 1989 Dec;4 Suppl 4:90-1.

9

Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease.识别髓系白血病细胞的同种异体T细胞对T细胞受体（TCR）Vβ的优先使用：对区分移植物抗白血病效应与移植物抗宿主病的意义。

Bone Marrow Transplant. 1997 May;19(9):899-903. doi: 10.1038/sj.bmt.1700769.

10

Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.使用供体淋巴细胞进行异基因细胞介导的免疫疗法，以预防接受异基因骨髓移植治疗血液系统恶性肿瘤的患者复发。

Clin Transpl. 1996:281-90.

引用本文的文献

1

CD4CD8 T-Lymphocytes in Xenogeneic and Human Graft-versus-Host Disease.异种移植物抗宿主病和人移植物抗宿主病中的 CD4CD8 T 淋巴细胞。

Front Immunol. 2020 Nov 24;11:579776. doi: 10.3389/fimmu.2020.579776. eCollection 2020.

2

Prevention of GVHD without losing GVL effect: windows of opportunity.在不丧失移植物抗肿瘤效应的情况下预防移植物抗宿主病：机会之窗。

Immunol Res. 2011 Apr;49(1-3):49-55. doi: 10.1007/s12026-010-8193-7.

3

Graft-versus-host disease after donor leukocyte infusions: presentation and management.供体白细胞输注后的移植物抗宿主病：表现与管理

Best Pract Res Clin Haematol. 2008 Jun;21(2):205-22. doi: 10.1016/j.beha.2008.02.007.